Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Xortx Pharma Corp.
DescriptionSmall molecule xanthine oxidase inhibitor
Molecular Target Xanthine oxidase
Mechanism of ActionXanthine oxidase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationPolycystic kidney disease (PKD)
Indication DetailsTreat polycystic kidney disease (PKD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today